Virios Therapeutics Inc/$DWTX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Virios Therapeutics Inc
Dogwood Therapeutics Inc, formerly Virios Therapeutics Inc, is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a virus-triggered abnormal immune response, such as fibromyalgia (FM) and long COVID (LC). Its product candidates include IMC-1 and IMC-2. IMC-1 is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.
Ticker
$DWTX
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
12
ISIN
US92829J2033
Website
DWTX Metrics
BasicAdvanced
$10M
-
-$20.92
2.00
-
Price and volume
Market cap
$10M
Beta
2
52-week high
$14.69
52-week low
$2.76
Average daily volume
1.7M
Financial strength
Current ratio
7.428
Quick ratio
6.799
Long term debt to equity
0.17
Total debt to equity
0.231
Interest coverage (TTM)
-58.55%
Management effectiveness
Return on assets (TTM)
-19.14%
Return on equity (TTM)
-54.42%
Valuation
Price to book
-0.57
Price to tangible book (TTM)
-0.34
Price to free cash flow (TTM)
-0.505
Growth
Earnings per share change (TTM)
213.69%
3-year earnings per share growth (CAGR)
-25.56%
DWTX News
AllArticlesVideos
Dogwood Therapeutics Announces First Quarter 2025 Financial Results
GlobeNewsWire·2 weeks ago
Dogwood Therapeutics, Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference
Newsfile Corp·3 weeks ago
Dogwood Therapeutics, Inc. Receives Nasdaq Confirmation of Compliance
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Virios Therapeutics Inc stock?
Virios Therapeutics Inc (DWTX) has a market cap of $10M as of May 23, 2025.
What is the P/E ratio for Virios Therapeutics Inc stock?
The price to earnings (P/E) ratio for Virios Therapeutics Inc (DWTX) stock is 0 as of May 23, 2025.
Does Virios Therapeutics Inc stock pay dividends?
No, Virios Therapeutics Inc (DWTX) stock does not pay dividends to its shareholders as of May 23, 2025.
When is the next Virios Therapeutics Inc dividend payment date?
Virios Therapeutics Inc (DWTX) stock does not pay dividends to its shareholders.
What is the beta indicator for Virios Therapeutics Inc?
Virios Therapeutics Inc (DWTX) has a beta rating of 2. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.